Among VFC-eligible children born during 2011 to 2020, coverage by age 24 months with one or more MMR dose and the combined seven-vaccine series was stable.
The vaccines have prevented an estimated 508 million cases of illness, 32 million hospitalizations, and 1.1 million deaths.
Children with a vaccine-hesitant parent varied by vaccine: 56% for COVID, 31% for flu, 30% for HPV, and 12% for other childhood illnesses.
But progress was made as well, with global uptake of at least one dose of HPV vaccine in girls increasing to 27% in 2023 from 20% in 2022.
The vaccine candidate covers the five groups of Neisseria meningitidis bacteria that cause most cases of invasive meningococcal disease.
Children whose families had more than $75,000 in annual income had a 4.6% mean annual increase in on-time vaccination.
A literature review found pneumococcal conjugate vaccines were associated with some protection against flu and other viral respiratory tract infections.
Senate Bill 2994A, was passed by New York lawmakers in June 2019 following two large measles outbreaks.
In the COVID-19 pandemic years 2020 to 2021, IPD incidence dipped to a low of 1.6 per 100,000 children.
The number of zero-dose children (14.3 million) decreased 21%, from 18.1 million in 2021, but was still 11% higher than the 12.9 million in 2019.
